CVC Capital Partners VIII to invest in Rayner
CVC Capital Partners VIII has agreed to acquire a majority interest in Rayner, the global ophthalmology business from Phoenix Equity Partners, the UK growth-focused private equity firm, for an undisclosed amount. Rayner is a manufacturer and developer of innovative intraocular lenses (IOLs) and associated pharmaceuticals. The Company’s products deliver sight-restorative
